Abbott Sells IVD, Point-Of-Care Diagnostics To GE For $8.13 Bil.

With GE's $8.13 billion cash purchase of Abbott Laboratories' core in vitro diagnostics unit Jan. 18, the corporate giant is betting it can accelerate growth in a business still recovering from protracted regulatory challenges in the U.S